MRK | tickerfilter.com

Fundamental analysis

58%

Profitability 56%

Dept financing 19%

Liquidity 62%

Performance 69%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

5.08%

1 Month

-7.27%

3 Months

-15.09%

6 Months

-20.62%

1 Year

-36.41%

2 Year

-28.35%

Key data

Stock price

$82.74

P/E Ratio

14.70

DAY RANGE

$78.06 - $83.28

EPS

$6.76

52 WEEK RANGE

$75.93 - $134.63

52 WEEK CHANGE

-$36.41

MARKET CAP

251.648 B

YIELD

3.14%

SHARES OUTSTANDING

2.533 B

DIVIDEND

$0.81

EX-DIVIDEND DATE

03-17-2025

NEXT EARNINGS DATE

07-29-2025

BETA

0.31

PUBLIC FLOAT

AVERAGE 10 VOLUME

$17,742,674

AVERAGE 30 VOLUME

$17,864,697

Company detail

CEO: Robert M. Davis
Region: US
Website: merck.com
Employees: 69,000
IPO year: 1970

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Merck & Co. operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services.

MRK - Merck & Co., Inc.